prostate cancer in the covid era: systemic therapy for mcrpc
Published 4 years ago • 8 plays • Length 6:45Download video MP4
Download video MP3
Similar videos
-
6:53
prostate cancer in the covid era: radiation therapy for mcrpc
-
2:18
prostate cancer in the covid era: metastatic hormone-sensitive prostate cancer
-
9:39
prostate cancer in the covid era: localized prostate cancer
-
39:02
systemic therapies for the treatment of advanced prostate cancer
-
1:16
mcrpc: advice for treatment during covid-19
-
46:50
mcrpc and nmcrpc: combinations and latest data, what does covid mean for early treatment?
-
11:05
rcc in the covid era: immunotherapy for metastatic cancer
-
8:33
bladder cancer in the covid era: metastatic cancers and the role of clinical trials
-
4:56
systemic therapy for nonmetastatic castrate-resistant prostate cancer
-
45:27
5.27.2020 urology covid didactics - active surveillance for early stage prostate cancer
-
51:25
11.23.2020 urology covid didactics - management of advanced prostate cancer
-
4:08
significant impact of covid-19 on the treatment of mcrpc
-
18:25
practical advice for prostate cancer patients for weathering changes caused by covid-19
-
51:48
4.30.2020 urology covid didactics - treatment for clinically localized prostate cancer
-
13:00
what prostate cancer patients need to know about treatment during the covid-19 pandemic
-
3:55
optimal treatment approaches for mcrpc
-
5:16
significance of the era 223 trial in mcrpc
-
2:50
the differences between mcrpc and nmcrpc
-
8:21
ep. 10: how has the mcrpc treatment landscape changed?